Clinical Trial Update: Mantel Cell Lymphoma Efficacy of Rituximab Maintenance [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating rituximab maintenance in mantle cell lymphoma has completed, with results on its efficacy reported in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: French Innovative Leukemia Organisation | Conditions: Mantle Cell Lymphoma | Phase 3 | Status: COMPLETED